{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:30:16Z","timestamp":1777386616873,"version":"3.51.4"},"reference-count":30,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T00:00:00Z","timestamp":1592956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Am J Rhinol\ufffdAllergy"],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chronic rhinosinusitis (CRS) is a common chronic condition classically divided into two phenotypes according to the presence or absence of nasal polyps. The effects of both medical and surgical treatment are often temporary, encouraging research into new treatment options.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a systematic review related to dosages, effects, side effects, and safety of intrapolyp steroid injection in patients with nasal polyps. We identified five studies with a total of 386 patients and 2490 intrapolyp steroid injections.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Treatment with intrapolyp steroid injection leads to a decrease in the Total Nasal Polyps Score (TNPS), Total Nasal Symptom Score (TNSS), and Lund-Mackay Score. The dosage regimens vary from 10 to 40\u2009mg triamcinolone acetonide. Only two cases of temporary visual complications were reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This review found that intrapolyp steroid injection may be an effective and safe treatment for patients with nasal polyps. However, there exist no large, randomized, clinical trials. We found no association between dose and effect, or dose and the risk of visual complications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/1945892420936198","type":"journal-article","created":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T08:35:58Z","timestamp":1592987758000},"page":"838-845","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":8,"title":["Injection of Steroid in Nasal Polyps: A Systematic Review"],"prefix":"10.1177","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3578-1201","authenticated-orcid":false,"given":"Maria B.","family":"Hansen","sequence":"first","affiliation":[{"name":"Department of Otorhinolaryngology \u2013 Head and Neck Surgery and Audiology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikkel C.","family":"Alanin","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology \u2013 Head and Neck Surgery and Audiology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2020,6,24]]},"reference":[{"key":"bibr1-1945892420936198","unstructured":"Danish Rhinologic Society. Kronisk rhinosinuitis med og uden nasal polypose. Published online May 2015."},{"issue":"29","key":"bibr2-1945892420936198","first-page":"1","volume":"58","author":"Fokkens WJ","year":"2020","journal-title":"Rhinology"},{"key":"bibr3-1945892420936198","unstructured":"Mayo Clinic. Nasal polyps. www.mayoclinic.org. Published July 11, 2019. Accessed February 6, 2020. https:\/\/www.mayoclinic.org\/diseases-conditions\/nasal-polyps\/symptoms-causes\/syc-20351888."},{"key":"bibr4-1945892420936198","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2011.02646.x"},{"key":"bibr5-1945892420936198","doi-asserted-by":"publisher","DOI":"10.1111\/coa.12189"},{"key":"bibr6-1945892420936198","doi-asserted-by":"publisher","DOI":"10.1177\/00034894041130S502"},{"key":"bibr7-1945892420936198","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.02.020"},{"key":"bibr8-1945892420936198","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlg.0000191560.53555.08"},{"key":"bibr9-1945892420936198","first-page":"V05180344","volume":"118","author":"Richter Jensen M","year":"2018","journal-title":"Kronisk Rhinosinuitis. Ugeskr L\u00e6g"},{"key":"bibr10-1945892420936198","unstructured":"DanskL\u00e6gemiddel Information A\/S (DLI). Glukokortikoider. www.pro.medicin.dk. Published May 13, 2019. Accessed November 8 2019. https:\/\/pro.medicin.dk\/Laegemiddelgrupper\/Grupper\/171030#a000."},{"key":"bibr11-1945892420936198","doi-asserted-by":"publisher","DOI":"10.1002\/lary.20653"},{"key":"bibr12-1945892420936198","doi-asserted-by":"crossref","unstructured":"Loftus CA, Soler ZM, Koochakzadeh S, et\u00a0al. Revision surgery rates in chronic rhinosinusitis with nasal polyps: meta-analysis of risk factors.\n                      Int Forum Allergy Rhinol\n                      . 2020;10(2): 199\u2013207. doi:10.1002\/alr.22487","DOI":"10.1002\/alr.22487"},{"key":"bibr13-1945892420936198","unstructured":"Tthanai Pongdee MD. Aspirin-exacerbated respiratory disease | AAAAI. The American Academy of Allergy, Asthma & Immunology. Accessed November 13, 2019. https:\/\/www.aaaai.org\/conditions-and-treatments\/library\/asthma-library\/aspirin-exacerbated-respiratory-disease."},{"key":"bibr14-1945892420936198","doi-asserted-by":"crossref","unstructured":"Bachert C, Han JK, Desrosiers M, et\u00a0al. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.\n                      Lancet Lond Engl.\n                      Published online September 19, 2019. doi:10.1016\/S0140-6736(19)31881-1","DOI":"10.1016\/S0140-6736(19)31881-1"},{"key":"bibr15-1945892420936198","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.1952.00710020191009"},{"issue":"2","key":"bibr16-1945892420936198","first-page":"121","volume":"56","author":"Semenov H.","year":"1952","journal-title":"Trans Am Acad Ophthalmol Otolaryngol"},{"key":"bibr17-1945892420936198","doi-asserted-by":"publisher","DOI":"10.1288\/00005537-195801000-00001"},{"key":"bibr18-1945892420936198","doi-asserted-by":"publisher","DOI":"10.1177\/019459987908700210"},{"key":"bibr19-1945892420936198","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097"},{"key":"bibr20-1945892420936198","doi-asserted-by":"publisher","DOI":"10.1002\/lary.25945"},{"key":"bibr21-1945892420936198","doi-asserted-by":"publisher","DOI":"10.1002\/lary.25000"},{"key":"bibr22-1945892420936198","doi-asserted-by":"publisher","DOI":"10.1177\/0194599812446678"},{"key":"bibr23-1945892420936198","doi-asserted-by":"publisher","DOI":"10.2500\/ajr.2007.21.2971"},{"key":"bibr24-1945892420936198","doi-asserted-by":"publisher","DOI":"10.1177\/194589240101500607"},{"key":"bibr25-1945892420936198","first-page":"CD006549","volume":"12","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"bibr26-1945892420936198","doi-asserted-by":"publisher","DOI":"10.4193\/Rhin17.247"},{"key":"bibr27-1945892420936198","unstructured":"Dansk L\u00e6gemiddel Information A\/S (DLI). Prednisolon \u201cDAK.\u201d www.pro.medicin.dk. Accessed November 11, 2019. http:\/\/pro.medicin.dk\/medicin\/praeparater\/56#a240."},{"key":"bibr28-1945892420936198","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.1981.00790440024006"},{"key":"bibr29-1945892420936198","unstructured":"Dansk L\u00e6gemiddel Information A\/S (DLI). Dupixent. www.pro.medicin.dk. Published November 18, 2019. Accessed November 22, 2019. https:\/\/pro.medicin.dk\/medicin\/praeparater\/8524."},{"key":"bibr30-1945892420936198","unstructured":"Dansk L\u00e6gemiddel Information A\/S (DLI). Kenalog\u00ae. www.pro.medicin.dk. Published August 21, 2019. Accessed November 6, 2019. http:\/\/pro.medicin.dk\/Medicin\/Praeparater\/3706."}],"container-title":["American Journal of Rhinology &amp; Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1945892420936198","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1945892420936198","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1945892420936198","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T09:36:43Z","timestamp":1777369003000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1945892420936198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,24]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["10.1177\/1945892420936198"],"URL":"https:\/\/doi.org\/10.1177\/1945892420936198","relation":{},"ISSN":["1945-8924","1945-8932"],"issn-type":[{"value":"1945-8924","type":"print"},{"value":"1945-8932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,24]]}}}